Find all of our “September, 2008” entries here.
Our September, 2008 Archives
Health Matters: Gynecologic Oncology
About 1 in every 57 women in the United States will develop some type of gynecologic cancer. Most cases occur in women over the age of 50, but this disease can also affect younger women. Dr. Steven Plaxe discusses rmethods of diagnosis and treatment.
Melamine Contamination Spreads
CNN’s John Vause reports more dairy products have tested positive for the toxic chemical melamine.
RedScrubs Weekly Wrap-up 9-26-08
You may remember that a few weeks back, I told you that RedScrubs would be seeing some changes soon. I am excited to say that you will begin to see fresh daily content beginning today, including the top 3 medical blog posts, the top medical videos of the day, and a daily sampling of some of the top jobs out there.
The Scrubby Awards will also now feature a new “Top 3″ format, with our top winner and 2 runners’ up chosen from the week’s daily top blogs. The top winner will continue to receive a free pair of red scrubs from NWscrubs and our nifty “Scrubby Award” logo (seen above) to put on their site or blog post. If you have any comments about the changes, or have a post you would like to submit, please do so here. We love to hear from both our new and loyal readers!
-Dr. Incognito
Alabama Gastroenterologist LS2416x
Alabama Gastro. Join a well established single specialty group of GIs within close proximity to Atlanta and the gulfshore beaches. This group has the market share enabling you to be very busy from day 1.
Florida Med Peds LS2415x
Florida MedPeds. Enjoy working in a beautiful new office, fully equipped with excellent support and other MedPeds trained physicians who are young, well liked and highly respected. This area is a paradise to live and work, and the professional setting far exceeds all standards; the payor mix is what everyone dreams of, greater income potential than 90+% of all other locations.
Can your diagnosis be influenced by your physician’s personality traits?
According to a new study, a physician’s attitudes and personality traits may affect the tendency to diagnose mood swings or depression. Some physicians apparently are sensitive to certain topics such as depression or suicide and are reluctant to discuss these issues with patients regardless of need.
According to Dr. Duberstein, co-author of the study, depression is frequently not diagnosed and suicidal tendencies are not explored even went quite evident. Physicians should reflect on the possibility that their personal traits might taint their diagnosis – or lack thereof – in mental health situations.
Maine Gastroenterologist LL3493
BE/BC Gastroenterologist needed in southern Maine. Join group of 3 Gastroenterologists in a growth position. Potential partnership opportunity in Maine’s most desirable city.
Byetta: A Safe Choice For Diabetics?
Byetta is an injectable drug that has been prescribed mostly for type 2 diabetics with a weight problem. Because it can be taken along with a sulfonylurea or a thiazolidinedione, Byetta can be added to an existing drug regimen as needed. Not only does Byetta regulate insulin and glucose production, but it also slows the emptying of the stomach (so you feel fuller longer), and it reduces your appetite causing you to eat less. People taking Byetta have good luck with weight loss and better blood glucose control.
Unfortunately, there have been many cases of pancreatitis reported with the use of Byetta, as well as reported deaths, and as a result, the FDA is considering a black box warning for its label.
Folks, it looks like this drug is headed for the trash can. Well, overweight type 2 diabetics could always use exercise and a stringent diet to shed those life-sucking pounds. How many times does it need to be said: Proper diet and regular exercise are critical for a long and healthy life. The short-cuts just don’t work.
Safety Review: Vytorin and Increased Risk of All-Types Cancer
An early communication was released from the U.S. Food and Drug (FDA) administration regarding a study of the safety of Vytorin ( a combination of simvastin and ezetimibe). Vytorin is used to decrease LDL cholesterol – each by a different mechanism and affecting different pathways of cholesterol absorption and metabolism. FDA is currently investigating the report from the SEAS trial (Simvastin and Ezetimibe in Aortic Stenosis) to see if there is a possible association between the use of Vytorin and increased incidences of cancer.

